Literature DB >> 28363410

Factors Related to Pre-exposure Prophylaxis Prescription by U.S. Primary Care Physicians.

Jennifer L Walsh1, Andrew E Petroll2.   

Abstract

INTRODUCTION: Although pre-exposure prophylaxis (PrEP) greatly reduces risk of HIV infection in HIV-negative individuals, use is not widespread enough to impact HIV incidence. Involvement of primary care physicians (PCPs) in PrEP prescription is essential, but previous research has shown low rates of prescription among PCPs. To identify targets for interventions, the information-motivation-behavioral skills model for PrEP discussion and prescription was tested in a ten-city sample of PCPs.
METHODS: PCPs from ZIP codes with high HIV incidence in ten U.S. cities (N=280, 52% male, 56% white) completed a survey online between July 2014 and May 2015. Information items assessed knowledge, motivation items evaluated attitudes, and behavioral skills items measured comfort with behaviors involved in prescribing PrEP. Providers indicated whether they had discussed PrEP with or prescribed PrEP to patients. Data were analyzed in 2015 and 2016.
RESULTS: One third of PCPs had discussed and 17% had prescribed PrEP. A structural equation model with good fit supported the information-motivation-behavioral skills model. Information and motivation predicted behavioral skills (b=0.35, 95% CI=0.13, 0.57; and b=0.31, 95% CI=0.14, 0.47, respectively). Behavioral skills predicted prescription (b=0.27, 95% CI=0.12, 0.42). Furthermore, behavioral skills mediated effects of information and motivation on prescription (b=0.10, 95% CI=0.03, 0.19; and b=0.08, 95% CI=0.03, 0.16, respectively).
CONCLUSIONS: The information-motivation-behavioral skills model can be applied to PCPs' PrEP discussion and prescription. Its constructs represent potential targets for PCP-directed interventions to increase PrEP use in high-risk populations.
Copyright © 2017 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28363410      PMCID: PMC5438776          DOI: 10.1016/j.amepre.2017.01.025

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  27 in total

1.  Nurses' attitudes, subjective norms, and behavioral intentions toward support of breastfeeding mothers.

Authors:  L W Bernaix
Journal:  J Hum Lact       Date:  2000-08       Impact factor: 2.219

2.  Preexposure prophylaxis for HIV infection: healthcare providers' knowledge, perception, and willingness to adopt future implementation in the southern US.

Authors:  Avnish Tripathi; Chinelo Ogbuanu; Mauda Monger; James J Gibson; Wayne A Duffus
Journal:  South Med J       Date:  2012-04       Impact factor: 0.954

Review 3.  Changing AIDS-risk behavior.

Authors:  J D Fisher; W A Fisher
Journal:  Psychol Bull       Date:  1992-05       Impact factor: 17.737

4.  Prediction of pharmacist intention to provide Medicare medication therapy management services using the theory of planned behavior.

Authors:  Kathleen E Herbert; Julie M Urmie; Brand A Newland; Karen B Farris
Journal:  Res Social Adm Pharm       Date:  2006-09

Review 5.  HIV pre-exposure prophylaxis (PrEP): a review of current knowledge of oral systemic HIV PrEP in humans.

Authors:  Christoph D Spinner; Christoph Boesecke; Alexander Zink; Heiko Jessen; Hans-Jürgen Stellbrink; Jürgen Kurt Rockstroh; Stefan Esser
Journal:  Infection       Date:  2015-10-15       Impact factor: 3.553

6.  RMediation: an R package for mediation analysis confidence intervals.

Authors:  Davood Tofighi; David P MacKinnon
Journal:  Behav Res Methods       Date:  2011-09

7.  Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men.

Authors:  Peter L Anderson; David V Glidden; Albert Liu; Susan Buchbinder; Javier R Lama; Juan Vicente Guanira; Vanessa McMahan; Lane R Bushman; Martín Casapía; Orlando Montoya-Herrera; Valdilea G Veloso; Kenneth H Mayer; Suwat Chariyalertsak; Mauro Schechter; Linda-Gail Bekker; Esper Georges Kallás; Robert M Grant
Journal:  Sci Transl Med       Date:  2012-09-12       Impact factor: 17.956

8.  Predicting pharmacists' adjustment of medication regimens in Ramadan using the Theory of Planned Behavior.

Authors:  Mohamed E K Amin; Betty Chewning
Journal:  Res Social Adm Pharm       Date:  2014-04-29

9.  Vital Signs: Estimated Percentages and Numbers of Adults with Indications for Preexposure Prophylaxis to Prevent HIV Acquisition--United States, 2015.

Authors:  Dawn K Smith; Michelle Van Handel; Richard J Wolitski; Jo Ellen Stryker; H Irene Hall; Joseph Prejean; Linda J Koenig; Linda A Valleroy
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-11-27       Impact factor: 17.586

10.  Vital Signs: Increased Medicaid Prescriptions for Preexposure Prophylaxis Against HIV infection--New York, 2012-2015.

Authors:  Franklin N Laufer; Daniel A O'Connell; Ira Feldman; Howard A Zucker
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-11-27       Impact factor: 17.586

View more
  21 in total

Review 1.  Evolving Models and Ongoing Challenges for HIV Preexposure Prophylaxis Implementation in the United States.

Authors:  Kenneth H Mayer; Philip A Chan; Rupa R Patel; Charlene A Flash; Douglas S Krakower
Journal:  J Acquir Immune Defic Syndr       Date:  2018-02-01       Impact factor: 3.731

2.  Knowing versus doing: The value of behavioral change models for emotional communication in oncology.

Authors:  Bryan A Sisk; Jennifer W Mack; James DuBois
Journal:  Patient Educ Couns       Date:  2019-07-24

3.  HIV Post-Exposure Prophylaxis (PEP) Awareness and Non-Occupational PEP (nPEP) Prescribing History Among U.S. Healthcare Providers.

Authors:  Steven A John; Katherine G Quinn; Benedikt Pleuhs; Jennifer L Walsh; Andrew E Petroll
Journal:  AIDS Behav       Date:  2020-11

4.  Health Care Provider Barriers to HIV Pre-Exposure Prophylaxis in the United States: A Systematic Review.

Authors:  Benedikt Pleuhs; Katherine G Quinn; Jennifer L Walsh; Andrew E Petroll; Steven A John
Journal:  AIDS Patient Care STDS       Date:  2020-02-28       Impact factor: 5.078

5.  HIV Pre-Exposure Prophylaxis Implementation Cascade Among Health Care Professionals in the United States: Implications from a Systematic Review and Meta-Analysis.

Authors:  Chen Zhang; James McMahon; Kevin Fiscella; Sarahmona Przybyla; Amy Braksmajer; Natalie LeBlanc; Yu Liu
Journal:  AIDS Patient Care STDS       Date:  2019-12       Impact factor: 5.078

6.  Awareness, knowledge, and attitudes towards human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP) among pharmacy students.

Authors:  Sarahmona M Przybyla; Kathleen Parks; Jacob Bleasdale; Joshua Sawyer; Diane Morse
Journal:  Curr Pharm Teach Learn       Date:  2019-02-23

7.  Missed Opportunities to Prescribe HIV Pre-Exposure Prophylaxis by Primary Care Providers in Saint Louis, Missouri.

Authors:  Rupa R Patel; Philip A Chan; Laura C Harrison; Kenneth H Mayer; Amy Nunn; Leandro A Mena; William G Powderly
Journal:  LGBT Health       Date:  2018-04-24       Impact factor: 4.151

8.  Training health care providers to provide PrEP for HIV serodiscordant couples attending public health facilities in Kenya.

Authors:  Elizabeth M Irungu; Kenneth Ngure; Kenneth Mugwanya; Nelly Mugo; Elizabeth Bukusi; Elizabeth Wamoni; Josephine Odoyo; Jennifer F Morton; Gena Bernabee; Barbara Mambo; Sarah Masyuko; Irene Mukui; Gabrielle O'Malley; Jared M Baeten
Journal:  Glob Public Health       Date:  2019-03-14

9.  Student Education About Pre-exposure Prophylaxis (PrEP) Varies Between Regions of the United States.

Authors:  Samuel R Bunting; Sarah S Garber; Robert H Goldstein; Timothy D Ritchie; Tamzin J Batteson; Timothy J Keyes
Journal:  J Gen Intern Med       Date:  2020-02-20       Impact factor: 5.128

10.  A Longitudinal, Qualitative Exploration of Perceived HIV Risk, Healthcare Experiences, and Social Support as Facilitators and Barriers to PrEP Adoption Among Black Women.

Authors:  Liesl A Nydegger; Julia Dickson-Gomez; Thant Ko Ko
Journal:  AIDS Behav       Date:  2021-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.